Stay updated on ASP1517 Intermittent Dosing in CKD Anemia Clinical Trial
Sign up to get notified when there's something new on the ASP1517 Intermittent Dosing in CKD Anemia Clinical Trial page.

Latest updates to the ASP1517 Intermittent Dosing in CKD Anemia Clinical Trial page
- Check5 days agoChange DetectedThe page now displays the ClinicalTrials.gov record for the ASP1517/roxadustat anemia study, including its design, eligibility criteria, outcomes, locations, and record dates.SummaryDifference84%

- Check12 days agoChange DetectedThe footer revision label changes from v3.7.2 to v3.8.0.SummaryDifference0.2%

- Check19 days agoChange DetectedA banner announces NIH website transition updates and says that federal agencies are using “Super Intelligence” in place of “Artificial Intelligence” during the transition.SummaryDifference1%

- Check26 days agoChange DetectedThe footer revision label changed from v3.7.1 to v3.7.2.SummaryDifference0.2%

- Check33 days agoChange DetectedThe footer revision identifier changed from v3.7.0 to v3.7.1, while the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check54 days agoChange DetectedThe page now renders a 403 Forbidden error, with the site header/footer visible, replacing the previous study details and navigation and indicating access to the study record is blocked.SummaryDifference18%

Stay in the know with updates to ASP1517 Intermittent Dosing in CKD Anemia Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ASP1517 Intermittent Dosing in CKD Anemia Clinical Trial page.